Market revenue in 2022 | USD 37.4 million |
Market revenue in 2030 | USD 113.2 million |
Growth rate | 14.9% (CAGR from 2022 to 2030) |
Largest segment | Solid-phase synthesis |
Fastest growing segment | PCR-based Enzyme Synthesis |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis |
Key market players worldwide | Genscript Biotech Corp Class H, Brooks Automation, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies |
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis market will help companies and investors design strategic landscapes.
Solid-phase synthesis was the largest segment with a revenue share of 36.1% in 2022. Horizon Databook has segmented the Middle East & Africa gene synthesis market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East and Africa (MEA) region is anticipated to witness growth in the gene synthesis market due to increasing investments and strategic initiatives from local governments toward development of biotechnological capabilities.
For instance, the Kingdom of Saudi Arabia had a budget of around USD 46 billion for social care and healthcare in 2019, representing tremendous opportunities for investments in medical applications of emerging technologies, such as gene synthesis.
Furthermore, organizations such as SaudiVax are coordinating cell & gene therapy development activities for enhancing access to these therapies in the Middle East and North Africa, which, in turn, can boost the growth prospects for gene synthesis technologies.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa gene synthesis market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa gene synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account